IL33 and neoplasm: Motivated by the aforementioned findings and recognizing the potent capacity of IL-33 to induce activation of ILC2s, we subsequently employed IL-33 to delineate and compare the impacts of IL-33 deficiency on the dynamic patterns of tumor growth.